• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的经济负担。

The economic burden of heart failure.

作者信息

O'Connell J B

机构信息

Department of Internal Medicine, University Health Center, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

Clin Cardiol. 2000 Mar;23(3 Suppl):III6-10. doi: 10.1002/clc.4960231503.

DOI:10.1002/clc.4960231503
PMID:10754775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6654942/
Abstract

Heart failure, a major cause of morbidity and mortality among the elderly, is a serious public health problem. As the population ages and the prevalence of heart failure increases, expenditures related to the care of these patients will climb dramatically. As a result, the health care industry must develop strategies to contain this staggering economic burden. Strategies may include adopting approaches for preventing heart failure and implementing new treatment modalities with proven efficacy into large-scale clinical practice. Successful implementation of these strategies will require intensive physician and patient education and development of innovative approaches to fund support services.

摘要

心力衰竭是老年人发病和死亡的主要原因,是一个严重的公共卫生问题。随着人口老龄化以及心力衰竭患病率的上升,与这些患者护理相关的支出将大幅攀升。因此,医疗行业必须制定策略来控制这一惊人的经济负担。策略可能包括采用预防心力衰竭的方法,并将已证实有效的新治疗模式应用于大规模临床实践。成功实施这些策略将需要加强医生和患者教育,并开发创新的资金支持服务方法。

相似文献

1
The economic burden of heart failure.心力衰竭的经济负担。
Clin Cardiol. 2000 Mar;23(3 Suppl):III6-10. doi: 10.1002/clc.4960231503.
2
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.美国一家学术医疗中心射血分数降低的心力衰竭患者的药物治疗模式、治疗结果及卫生资源利用情况
Pharmacotherapy. 2016 Feb;36(2):174-86. doi: 10.1002/phar.1701. Epub 2016 Feb 3.
3
Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure.
Eur Heart J. 1995 Dec;16 Suppl N:59-64. doi: 10.1093/eurheartj/16.suppl_n.59.
4
Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.血浆去甲肾上腺素在无症状左心室功能不全患者中的预后意义。SOLVD研究人员。
Circulation. 1996 Aug 15;94(4):690-7. doi: 10.1161/01.cir.94.4.690.
5
Heart failure mortality among older Medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use.老年医疗保险受益人的心力衰竭死亡率:与左心室功能评估及血管紧张素转换酶抑制剂使用的关联
South Med J. 2003 Feb;96(2):124-9. doi: 10.1097/01.SMJ.0000051271.11872.50.
6
[Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].[瑞士慢性心力衰竭治疗中血管紧张素转换酶抑制剂的成本效益:基于SOLVD研究的评估]
Schweiz Med Wochenschr. 1997 Jul 22;127(29-30):1234-41.
7
Cost-effective management of heart failure.
Clin Cardiol. 1996 Mar;19(3):240-2. doi: 10.1002/clc.4960190319.
8
Underutilisation of ACE inhibitors in patients with congestive heart failure.充血性心力衰竭患者中血管紧张素转换酶抑制剂的使用不足。
Drugs. 2001;61(14):2021-33. doi: 10.2165/00003495-200161140-00002.
9
Current controversies with ACE inhibitor treatment in heart failure.心力衰竭中使用血管紧张素转换酶抑制剂治疗的当前争议。
Cardiology. 1996;87 Suppl 1:23-8. doi: 10.1159/000177164.
10
Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.合并症对以左心室功能障碍和心力衰竭为主的患者结局和血管紧张素转换酶抑制剂效果的影响。
Eur J Heart Fail. 2014 Mar;16(3):325-33. doi: 10.1002/ejhf.23. Epub 2014 Jan 23.

引用本文的文献

1
[Palliative care needs of heart failure patients: A mixed-method studyNecessidades de cuidados paliativos de pacientes com insuficiencia cardíaca: um estudo misto].心力衰竭患者的姑息治疗需求:一项混合方法研究 心力衰竭患者的姑息护理需求:一项混合研究
Rev Cuid. 2023 May 28;14(1):e10. doi: 10.15649/cuidarte.2539. eCollection 2023 Jan-Apr.
2
GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.生长分化因子 15:急性心力衰竭综合征患者心力衰竭再住院和短期死亡率的新型生物标志物预测
BMC Cardiovasc Disord. 2024 Mar 12;24(1):151. doi: 10.1186/s12872-024-03802-5.
3
Contemporary aetiology of acute heart failure in a teaching hospital in Ghana.加纳教学医院急性心力衰竭的当代病因学。
BMC Cardiovasc Disord. 2023 Feb 10;23(1):82. doi: 10.1186/s12872-023-03103-3.
4
Characteristics of emergency department admissions with congestive heart failure in the United States: a Nationwide cross-sectional study.美国充血性心力衰竭急诊入院患者的特征:一项全国性横断面研究。
BMC Emerg Med. 2022 Jan 28;22(1):16. doi: 10.1186/s12873-021-00564-7.
5
Automated Assessment of the Quality of Phonocardographic Recordings through Signal-to-Noise Ratio for Home Monitoring Applications.通过信噪比对心音描记记录进行自动评估,用于家庭监测应用。
Sensors (Basel). 2021 Oct 30;21(21):7246. doi: 10.3390/s21217246.
6
Neutrophil extracellular traps impair regeneration.中性粒细胞胞外陷阱可损害组织再生。
J Cell Mol Med. 2021 Nov;25(21):10008-10019. doi: 10.1111/jcmm.16896. Epub 2021 Oct 8.
7
Investigation of Relationship between Occupational Stress and Cardiovascular Risk Factors among Nurses.护士职业压力与心血管危险因素之间的关系调查
Iran J Public Health. 2020 Oct;49(10):1954-1958. doi: 10.18502/ijph.v49i10.4699.
8
Understanding Barriers to and Facilitators of Case Management in Primary Care: A Systematic Review and Thematic Synthesis.理解初级保健中病例管理的障碍和促进因素:系统评价和主题综合。
Ann Fam Med. 2020 Jul;18(4):355-363. doi: 10.1370/afm.2555.
9
β-Adrenergic receptor, an essential target in cardiovascular diseases.β-肾上腺素能受体,心血管疾病的重要靶点。
Heart Fail Rev. 2020 Mar;25(2):343-354. doi: 10.1007/s10741-019-09825-x.
10
The Impact of Pazopanib on the Cardiovascular System.帕唑帕尼对心血管系统的影响。
J Cardiovasc Pharmacol Ther. 2018 Sep;23(5):387-398. doi: 10.1177/1074248418769612. Epub 2018 Apr 29.

本文引用的文献

1
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
Am J Cardiol. 1999 May 1;83(9):1303-7. doi: 10.1016/s0002-9149(99)00117-4.
2
Heart failure.
Cardiol Clin. 1999 Feb;17(1):123-35. doi: 10.1016/s0733-8651(05)70060-6.
3
Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population.美国老年人的心力衰竭生存率:医疗保险人群中这一新兴流行病的预后不佳。
Arch Intern Med. 1999 Mar 8;159(5):505-10. doi: 10.1001/archinte.159.5.505.
4
The American health care system--the movement for improved quality in health care.美国医疗保健系统——提高医疗保健质量的运动。
N Engl J Med. 1999 Feb 11;340(6):488-92. doi: 10.1056/NEJM199902113400621.
5
Results of the ATLAS study. High or low doses of ACE inhibitors for heart failure?
Cleve Clin J Med. 1998 Nov-Dec;65(10):539-42. doi: 10.3949/ccjm.65.10.539.
6
Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.医师在充血性心力衰竭住院治疗中使用血管紧张素转换酶抑制剂的模式。
J La State Med Soc. 1997 Dec;149(12):474-84.
7
Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center.1986年至1994年间的心力衰竭:学术医疗中心药物处方实践、医院再入院率和生存率的时间趋势。
Am Heart J. 1997 Nov;134(5 Pt 1):901-9. doi: 10.1016/s0002-8703(97)80013-0.
8
National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.充血性心力衰竭患者使用血管紧张素转换酶抑制剂的全国模式。
Arch Intern Med. 1997 Nov 24;157(21):2460-4.
9
Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.老年人充血性心力衰竭的流行病学、病理生理学及病因学
J Am Geriatr Soc. 1997 Aug;45(8):968-74. doi: 10.1111/j.1532-5415.1997.tb02968.x.
10
Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management.心力衰竭流行病学因素的演变趋势:预防策略和综合疾病管理的基本原理
Am Heart J. 1997 Jun;133(6):703-12. doi: 10.1016/s0002-8703(97)70173-x.